EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut microbiome: a novel preventive and therapeutic target for prostatic disease

Hongliang Cao, Difei Zhang, Pengyu Wang, Yishu Wang, Chengdong Shi, Hao Wu, Hao Du, Wenqiang Zhang, Zixuan Gou, Honglan Zhou, Song Wang

Frontiers in Cellular and Infection Microbiology · 29.07.2024 · 14

DOI: 10.3389/fcimb.2024.1431088 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 29.07.2024. Verfasst von Hongliang Cao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology II, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Prostatic Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human gut microbiome (GM) impacts various physiological processes and can lead to pathological conditions and even carcinogenesis if homeostasis is disrupted. Recent studies have indicated a connection between the GM and prostatic disease. However, the underlying mechanisms are still unclear. This review aims to provide a summary of the existing information regarding the connection between the GM and various prostatic conditions such as chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), benign prostatic hyperplasia (BPH), and prostate cancer (PCa). Furthermore, the review aims to identify possible pathogenic mechanisms and suggest potential ways of targeting GM to prevent and treat prostatic disease. Due to the complexity of the mechanism between GM and prostatic diseases, additional research is required to comprehend the association between the two. This will lead to more effective treatment options for prostatic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeProstatic DiseasesHumansMaleInflammationMetabolomeDietFecal Microbiota TransplantationMedicine, Chinese Traditional

Stichwörter der Autor:innen

benign prostatic hyperplasiagut microbiomeprostate cancerprostatitistherapy

Autor:innen und Institutionen

  • Department of Urology II, The First Hospital of Jilin University, Changchun, China.
  • Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, China.
  • Bethune First Clinical School of Medicine, The First Hospital of Jilin University, Changchun, China.

Zitieren

APA

Cao, H., Zhang, D., Wang, P., Wang, Y., Shi, C., Wu, H., Du, H., Zhang, W., Gou, Z., Zhou, H., & Wang, S. (2024). Gut microbiome: a novel preventive and therapeutic target for prostatic disease. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1431088

Vancouver

Cao H, Zhang D, Wang P, Wang Y, Shi C, Wu H, et al. Gut microbiome: a novel preventive and therapeutic target for prostatic disease. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1431088

BibTeX
@article{Cao2024,
  author = {Cao, Hongliang and Zhang, Difei and Wang, Pengyu and Wang, Yishu and Shi, Chengdong and Wu, Hao and Du, Hao and Zhang, Wenqiang and Gou, Zixuan and Zhou, Honglan and Wang, Song},
  title = {Gut microbiome: a novel preventive and therapeutic target for prostatic disease},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fcimb.2024.1431088}
}
Kostenlos starten →